By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

New Christian Doppler laboratory conducts research into children‘s cancer

Michael Traxlmayr, Manfred Lehner © St Anna Children’s Cancer Research

This therapy is currently being applied to a few patients at the present time, above all those with leukaemia, when other therapeutic approaches have been exhausted. The body's own immune cells, above all T-cells, have a strong ability to kill cancer cells. However, recurrent tumours have learned to present themselves in such a way that our immune cells can no longer recognize them as dangerous and kill them. In CAR-T cell therapy, cancer cells can be made visible again to the immune system by isolating T cells from the blood of patients and equipping them with artificially built-in receptors, so-called chimeric antigen receptors (CARs). The cells modified in this way are then administered to the patient where they are supposed to multiply and fight the cancer.

The new CD Laboratory is led by Manfred Lehner from the St. Anna Children's Research Institute in cooperation with Michael Traxlmayr from the Institute for Biochemistry at the University of Natural Resources and Applied Life Sciences (BOKU) and the industrial partner company Miltenyi Biotec. "The research goal is to generate molecular tools that can be used to better control CAR T cells in order to use them as targeted missiles against solid tumours," states Traxlmayr, head of the external CD Laboratory module. "Just like in a car, we need an accelerator and a brake to control the activity of the therapy, otherwise dangerous overreactions can occur. At the same time, we have to improve the controllability of the therapy considerably," explains Manfred Lehner, head of the CD Laboratory at the St. Anna Children's Cancer Research Institute.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • China International Fair for Investment & Trade

    08.09. - 11.09. 2020, Xiamen, China

  • Finanzgipfel 2020

    17.09.2020/ 08:00 , Frankfurt, Deutschland

Austria Map

Find the perfect location for your company

Reliability and expertise in the country and in the company are the convincing factors in selecting a business location. We can be justifiably proud but can still become even more attractive. This is something Austria should increasingly work on in the future!

Pfizer

Logo
More testimonials

news from the business location Austria

462 new, international companies. ABA – Invest in Austria looks back on a very successful year.

In 2019 ABA – Invest in Austria supported 462 international companies in setting up their business in Austria – compared to 2018 this shows an increase of 30 % and lead to nearly 5000 newly-created jobs.

“Cash or card?” - Austria, the coronavirus pandemic and the increasing trend towards cashless payment.

The number of cashless transactions in Austria has been increasing for years. This upward trend once again experienced a tremendous boost due to the coronavirus pandemic.

More news All blog posts